Latest Period
Q4 2025
- Info
- Insider Trading
- Financials
- Holders
Security Snapshot
Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share (QNRX) Institutional Ownership
CUSIP: 74907L409
13F Institutional Holders and Ownership History from Q1 2025 to Q1 2026
Institutions Reporting
18
Shares (Excl. Options)
842,827
Price
$14.43
- Type / Class
- Equity / American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share
- Symbol
- QNRX on Nasdaq
- Shares outstanding
- 843,913
- Price per share
- $6.60
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 842,827
- Total reported value
- $12,161,983
- % of total 13F portfolios
- 0%
- Share change
- +841,336
- Value change
- +$12,140,475
- Number of holders
- 18
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- QNRX - Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share is tracked under CUSIP 74907L409.
- 18 institutions reported positions in Q4 2025.
- 8 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 18 to 1 between Q4 2025 and Q1 2026.
- Reported value moved from $12,161,983 to $11,352.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Official SEC Source
Backed by Form 13F
Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.
See Original FilingInvestment Quick Answers
What is CUSIP 74907L409?
CUSIP 74907L409 identifies QNRX - Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Continue Investment Research
- Latest 13F filings for new institutional portfolio disclosures.
- Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
- Latest 10-Q/10-K reports to cross-check issuer fundamentals.
- Recent insider transactions for management buying/selling context.
- SEC investors directory and top value investors for manager-level discovery.
- All institutional ownership pages to compare adjacent CUSIP pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 74907L409:
Significant Owners of Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share (QNRX) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Stonepine Capital Management, LLC | 11% | +7% | $47,201,973 | +$3,465,711 | 3,271,100 | +7.9% | Stonepine Capital Management, LLC | 29 Jan 2026 |
| Woodline Partners LP | 9.5% | $38,298,838 | 2,785,370 | Woodline Partners LP | 31 Dec 2025 | |||
| INTEGRATED CORE STRATEGIES (US) LLC | 4.6% | -49% | $36,005,681 | +$9,858,888 | 2,618,595 | +38% | Integrated Core Strategies (US) LLC | 31 Dec 2025 |
| ARMISTICE CAPITAL, LLC | 5% | $7,049,313 | 1,081,183 | Armistice Capital, LLC | 31 Mar 2025 | |||
| Ikarian Capital, LLC | 13% | -50% | $3,052,472 | 211,538 | 0% | Ikarian Capital, LLC | 31 Jan 2026 | |
| Aberdeen Group plc | 8.9% | $1,082,250 | 75,000 | Aberdeen Group plc | 31 Dec 2025 | |||
| ADAR1 Capital Management, LLC | 6.9% | $483,309 | 58,230 | ADAR1 Capital Management, LLC | 31 Dec 2025 | |||
| Resolute Capital Asset Partners LLC | 8.5% | $671,000 | 50,000 | Resolute Capital Asset Partners LLC | 10 Oct 2025 |
As of 31 Dec 2025, 18 institutional investors reported holding 842,827 shares of Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share (QNRX). This represents 100% of the company’s total 843,913 outstanding shares.
Top 18 Institutional Shareholders
The largest institutional shareholders of Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share (QNRX) together control 100% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Ikarian Capital, LLC | 25% | 211,538 | 0.4% | $3,052,493 | |
| Woodline Partners LP | 9.4% | 79,582 | 0% | $1,148,368 | |
| Stonepine Capital Management, LLC | 9.3% | 78,189 | 0.9% | $1,128,267 | |
| Aberdeen Group plc | 8.9% | 75,000 | 0% | $1,082,250 | |
| MILLENNIUM MANAGEMENT LLC | 8.9% | 74,817 | 0% | $1,079,609 | |
| SummitTX Capital, L.P. | 7.7% | 64,795 | 0.03% | $934,992 | |
| BOOTHBAY FUND MANAGEMENT, LLC | 7.1% | 59,838 | 0.02% | $863,462 | |
| ADAR1 Capital Management, LLC | 6.9% | 58,230 | 0.06% | $840,259 | |
| AIGH Capital Management LLC | 5.8% | 49,323 | 0.21% | $711,731 | |
| Resolute Capital Asset Partners LLC | 3.6% | 30,000 | 0.21% | $432,900 | |
| Soleus Capital Management, L.P. | 3% | 25,000 | 0.02% | $360,750 | |
| Simplify Asset Management Inc. | 2.1% | 17,448 | 0% | $251,775 | |
| Centiva Capital, LP | 1.4% | 12,053 | 0.01% | $173,925 | |
| MORGAN STANLEY | 0.36% | 3,000 | 0% | $43,290 | |
| GAMMA Investing LLC | 0.25% | 2,084 | +650% | 0% | $30,072 |
| RHUMBLINE ADVISERS | 0.2% | 1,666 | +38% | 0% | $24,031 |
| SBI Securities Co., Ltd. | 0.03% | 247 | +12250% | 0% | $3,564 |
| UBS Group AG | 0% | 17 | +1600% | 0% | $245 |